-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Neutral on Moderna, Raises Price Target to $60

Benzinga·08/03/2026 18:42:25
语音播报
Citigroup analyst Geoff Meacham maintains Moderna (NASDAQ:MRNA) with a Neutral and raises the price target from $41 to $60.